Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza pneumonia.

F L Ruben1, T R Cate

  • 1Infectious Disease Unit, Montefiore Hospital, Pittsburgh, PA 15213.

Seminars in Respiratory Infections
|June 1, 1987
PubMed
Summary
This summary is machine-generated.

Influenza viruses constantly change, leading to susceptibility. Annual vaccination and early antiviral treatment are key to reducing severe influenza illness and complications, especially in high-risk groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choosing a route of administration for quadrivalent meningococcal polysaccharide vaccine: intramuscular versus subcutaneous.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.

The Journal of infectious diseases·2000
Same author

Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.

The Journal of infectious diseases·2000
Same author

Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature.

The Journal of infection·1998
Same author

Impact of influenza and other community-acquired viruses.

Seminars in respiratory infections·1998
Same author

Hepatitis B virus infection, hepatitis B vaccine, and hepatitis B immune globulin.

The Journal of family practice·1997
Same journal

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

Seminars in respiratory infections·2003
Same journal

Environmental infection control of tuberculosis.

Seminars in respiratory infections·2003
Same journal

Mycobacterium tuberculosis: the treatment of active disease.

Seminars in respiratory infections·2003
Same journal

Pediatric tuberculosis.

Seminars in respiratory infections·2003
Same journal

Clinical and radiographic features of HIV-related tuberculosis.

Seminars in respiratory infections·2003
Same journal

Treatment of latent tuberculosis infection.

Seminars in respiratory infections·2003
See all related articles

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Influenza viruses (A and B) undergo antigenic drift and shift, ensuring continuous population susceptibility.
  • Influenza predominantly affects children and young adults, but severe outcomes are highest in infants, the elderly, and those with chronic heart or lung conditions.

Purpose of the Study:

  • To summarize the epidemiology, complications, and management strategies for influenza infections.
  • To highlight the importance of vaccination and antiviral therapies in mitigating influenza's impact.

Main Methods:

  • Review of influenza virus characteristics, including antigenic drift and shift.
  • Analysis of influenza epidemiology, focusing on age-related incidence and severity.
  • Discussion of common complications, particularly secondary bacterial pneumonias.

Related Experiment Videos

  • Evaluation of treatment options, including amantadine and ribavirin, and preventive measures like vaccination.

    • Main Results:

    • Influenza causes diffuse pulmonary infiltrates and hypoxia, but secondary bacterial pneumonia (e.g., pneumococcal, Staphylococcus aureus) is a more frequent complication.
    • Empiric antibiotic therapy should cover common bacterial pathogens, with broader coverage for high-risk patients.
    • Amantadine therapy can shorten symptoms during influenza A epidemics.
    • Ribavirin aerosol shows promise for treating influenza virus pneumonia.
    • Annual vaccination significantly reduces morbidity and mortality in at-risk populations.

    Conclusions:

    • Influenza remains a significant public health threat due to viral evolution.
    • Preventive measures, primarily annual vaccination, are crucial for high-risk individuals.
    • Prompt diagnosis and appropriate treatment, including antivirals and antibiotics for secondary infections, are vital for managing severe influenza cases.